7/19/2010

The use of 18F-FDG PET/CT helped pinpoint in 40 out of 89 breast cancer patients tumor deposits that were not detected through other tests, including mammography, CT and ultrasound. "Our findings agree with other studies in promoting regular investigations such as tumor markers and 18F-FDG PET/CT rather than awaiting the developments of physical symptoms as suggested by current guidelines since the timely detection of early recurrence may have a major impact on therapy and survival," the researchers said.

Full Story:
HealthImaging.com

Related Summaries